Why the study?
Does local chemotherapy improve effusion-free survival in patients with malignant pericardial effusion?
Does local chemotherapy improve effusion-free survival in patients with malignant pericardial effusion?
Answers are grounded in this paper and cite their sources.
Local chemotherapy with platinum for malignant pericardial effusion is proposed as a safer and more rational alternative to sclerosing therapy, demonstrating favorable effusion-free survival.
We have read with great interest the article of Kunitoh et al, 2009 published recently on this Journal, about the use of intrapericardial Bleomycin in malignant pericardial effusion (MPE) with lung cancer. We appreciate the effort of trying a prospective, randomised study in this field, but we do not agree with the rationale and the method of the study.
No takes yet. Share an insight, caveat, or question.
Lestuzzi et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: